Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth

Download Sample

Published Date: June 2023

Aquaculture Vaccines Market focuses on the increment of the production level and the quality of the aquaculture lives, by providing treatment for various bacterial and viral infections in them.

The constant rise in global population as well as increasing food demand is leading to the fast growth of this market. Moreover, a progressive rise of antimicrobial resistant microbes as well as the demand for more food safety hazards is expected to push the growth of the Aquaculture Vaccines Market.

The report “Global Aquaculture Vaccines Market, By Route of Administrations (Spray vaccination, Oral vaccines, Injection vaccines, and Immersion vaccines), By Species (Fixed Mounting, Carps, Salmon, Surgeon, and Trout), By Type of Vaccines (Inactivated vaccines, Live vaccines, and Other Type of Vaccines), By Applications (Viral infection, Bacterial infection, Other Applications), and By Region (North America, Europe, Asian Pacific, Latin America, and Middle East & Africa) – Trends, Analysis, and Forecast till 2032”

Key Highlights:

In February 2015, MSD Animal Health registered one of its successful fish vaccines – “AQUAVAC Strep Si”. This vaccine was produced to induce protective immunity in warm water fishes against Streptococcus caused by S.iniae. This vaccine has been confirmed to offer protection for at least 12 weeks in lab studies and 34 weeks in field trials.

Analyst View:

The key factor driving the growth of the Aquaculture Vaccines market is the growing prevalence of fish diseases due to intensive fish farming and environmental contamination. The efforts towards the development and acceptance of new and successful fish vaccines have contributed more towards the growth of the target market. Additionally, the need and demand for safe and environment-friendly aquaculture as well as more focus towards human health concerns is expected to boost the growth of the Aquaculture Vaccines Market in future.

Browse 60 market data tables and 35 figures* through 140 slides and in-depth TOC on* “Global Aquaculture Vaccines Market, By Route of Administrations (Spray vaccination, Oral vaccines, Injection vaccines, and Immersion vaccines), By Species (Fixed Mounting, Carps, Salmon, Surgeon, and Trout), By Type of Vaccines (Inactivated vaccines, Live vaccines, and Other Type of Vaccines), By Applications (Viral infection, Bacterial infection, Other Applications), and By Region (North America, Europe, Asian Pacific, Latin America, and Middle East & Africa) – Trends, Analysis, and Forecast till 2032”

Key Market Insights from the report:

Aquaculture Vaccines Market accounted for US$ 381.4 million in 2022 and is estimated to be US$ 946.5 million by 2032 and is anticipated to register a CAGR of 9.0%. The Aquaculture Vaccines market is segmented based on Route of Administrations, Species, Type of Vaccines, Applications and by Region.

Based on Route of Administrations, Aquaculture Vaccines Market is classified into Spray Vaccination, Oral Vaccines, Injection Vaccines and Immersion Vaccines.
Based on Species, Aquaculture Vaccines Market is segmented into Fixed Mounting, Carps, Salmon, Surgeon, and Trout.
Based on Type of Vaccines, Aquaculture Vaccines Market is classified into Inactivated Vaccines, live Vaccines, and other type of vaccines.
Based on Applications, Aquaculture Vaccines Market can be segmented into Viral Infection, Bacterial Infection, and some other applications.
By Region, Aquaculture Vaccines Market is segmented into North America, Europe, Asian pacific, Latin America and Middle East and Africa.

Competitive Landscape & their strategies of Aquaculture Vaccines market:

The prominent players operating in the Aquaculture Vaccines market includes, HIPRA, Virbac, Zoetis Inc., Tecnovax, Merck& Co., Inc., Veterquimica S.A, Elanco, KoVax Ltd, Nisseiken Co., Ltd and Pfizer.